Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

mercuryblues

(15,795 posts)
1. The tax cuts they got
Mon Apr 23, 2018, 09:45 AM
Apr 2018

combined with the huge increases in their drug prices, they lay off employees?



https://www.nbcnews.com/business/consumer/epipen-maker-also-hiked-prices-slew-other-medications-n636981

"Mylan has raised the prices more than 20 percent on 24 products, and more than 100 percent on seven products," Maris wrote.

He warned that the Netherlands-based drugmaker — whose CEO Heather Bresch saw her compensation increase by nearly 700 percent from 2007 to 2015 — could draw "greater regulatory scrutiny and headline risk" as a result of such price boosts.

They include a stunning 542 percent increase for the drug ursodiol, which is a generic medication used to treat gallstones.

Maris also flagged a 444 percent increase in another generic drug, metoclopramide, which is commonly used to treat GERD, or gastroesophageal reflux disease as well as gastroparesis. Dicyclomine, a drug used to treat irritable bowel syndrome, had its price jacked up by 400 percent by Mylan.

Recommendations

0 members have recommended this reply (displayed in chronological order):

Latest Discussions»Region Forums»West Virginia»Mylan (EpiPen manufacture...»Reply #1